{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T02:42:02Z","timestamp":1769827322327,"version":"3.49.0"},"reference-count":63,"publisher":"Medknow","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:sec>\n            <jats:title\/>\n            <jats:p>Coronavirus disease 19 (COVID-19) has rapidly expanded to a global pandemic, resulting in significant morbidity and mortality. Even though predictors of infection remain unclear, age and preexisting cardiovascular conditions have been clearly identified as predictors of adverse outcomes and higher fatality rates. Since the virus infects host cells through angiotensin-converting enzyme 2 receptors, a key player in the renin-angiotensin-aldosterone system, the interaction between the cardiovascular system and the progression of COVID-19 is nowadays a focus of huge interest. In this review, the authors analyze the available and very recent evidence on the risk factors and mechanisms of the most relevant cardiovascular complications associated with COVID-19, including acute cardiac injury, myocarditis, stress-cardiomyopathy, ischemic myocardial injury, cytokine release syndrome, thrombotic disease, cardiac arrhythmias, heart failure, and cardiogenic shock. Finally, we discuss the cardiovascular impact of the therapies under investigation for COVID-19 treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.4103\/hm.hm_28_20","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T08:41:03Z","timestamp":1601368863000},"page":"67-74","source":"Crossref","is-referenced-by-count":6,"title":["Cardiovascular Complications of COVID-19"],"prefix":"10.4103","volume":"4","author":[{"given":"Joana","family":"Brito","sequence":"first","affiliation":[]},{"given":"Beatriz Valente","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Pedro Alves","family":"da Silva","sequence":"additional","affiliation":[]},{"given":"Nuno","family":"Cortez-Dias","sequence":"additional","affiliation":[]},{"given":"Doroteia","family":"Silva","sequence":"additional","affiliation":[]},{"given":"Jo\u00e3o R.","family":"Agostinho","sequence":"additional","affiliation":[]},{"given":"Tatiana","family":"Guimar","sequence":"additional","affiliation":[]},{"given":"Dulce","family":"Brito","sequence":"additional","affiliation":[]},{"given":"Fausto J.","family":"Pinto","sequence":"additional","affiliation":[]}],"member":"2581","reference":[{"key":"R2-2-20240511","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"R3-2-20240511","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"R4-2-20240511","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41569-020-0360-5","article-title":"COVID-19 and the cardiovascular system","volume":"17","author":"Zheng","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"R5-2-20240511","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA - J Am Med Assoc"},{"key":"R6-2-20240511","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med"},{"key":"R7-2-20240511","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijid.2020.03.017","article-title":"Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis","volume":"94","author":"Yang","year":"2020","journal-title":"Int J Infect Dis"},{"key":"R8-2-20240511","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study","volume":"8","author":"Yang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"R10-2-20240511","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00392-020-01626-9","article-title":"Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China","volume":"109","author":"Li","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"R11-2-20240511","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA J Am Med Assoc"},{"key":"R12-2-20240511","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.117.032380","article-title":"Status of hypertension in China: Results from the China hypertension survey, 2012-2015","volume":"137","author":"Wang","year":"2018","journal-title":"Circulation"},{"key":"R13-2-20240511","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa2006923","article-title":"Renin-angiotensin-aldosterone system blockers and the risk of Covid-19","volume":"382","author":"Mancia","year":"2020","journal-title":"N Engl J Med"},{"key":"R14-2-20240511","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa2008975","article-title":"Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19","volume":"382","author":"Reynolds","year":"2020","journal-title":"N Engl J Med"},{"key":"R15-2-20240511","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1001\/jama.2020.4326","article-title":"Characteristics and outcomes of 21 critically Ill patients With COVID-19 in washington state","volume":"323","author":"Arentz","year":"2020","journal-title":"JAMA J Am Med Assoc"},{"key":"R16-2-20240511","doi-asserted-by":"crossref","first-page":"m1966","DOI":"10.1136\/bmj.m1966","article-title":"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: Prospective cohort study","volume":"369","author":"Petrilli","year":"2020","journal-title":"BMJ"},{"key":"R17-2-20240511","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/cid\/ciaa415","article-title":"Obesity in patients younger than 60 years Is a risk factor for COVID-19 hospital admission","volume":"71","author":"Lighter","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R20-2-20240511","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin-angiotensin-aldosterone system inhibitors in patients with Covid-19","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N Engl J Med"},{"key":"R21-2-20240511","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/CIRCULATIONAHA.110.955369","article-title":"Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction","volume":"122","author":"Zhong","year":"2010","journal-title":"Circulation"},{"key":"R22-2-20240511","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","article-title":"Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: Celebrating the 20th anniversary of the discovery of ACE2","volume":"126","author":"Gheblawi","year":"2020","journal-title":"Circ Res"},{"key":"R23-2-20240511","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"key":"R24-2-20240511","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","volume":"63","author":"Liu","year":"2020","journal-title":"Sci China Life Sci"},{"key":"R25-2-20240511","doi-asserted-by":"crossref","first-page":"e2011122","DOI":"10.1001\/jamanetworkopen.2020.11122","article-title":"Assessment of Hypokalemia and Clinical Characteristics in Patients With Coronavirus Disease 2019 in Wenzhou, China","volume":"3","author":"Chen","year":"2020","journal-title":"JAMA Netw Open"},{"key":"R26-2-20240511","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-2362.2009.02153.x","article-title":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS","volume":"39","author":"Oudit","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"R27-2-20240511","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"R28-2-20240511","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N Engl J Med"},{"key":"R29-2-20240511","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","article-title":"Inflammation in atherosclerosis: From pathophysiology to practice","volume":"54","author":"Libby","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R30-2-20240511","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0140-6736(12)61266-5","article-title":"Acute pneumonia and the cardiovascular system","volume":"381","author":"Corrales-Medina","year":"2013","journal-title":"Lancet"},{"key":"R31-2-20240511","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"R32-2-20240511","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/eurheartj\/ehaa235","article-title":"SARS-CoV2: Should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?","volume":"41","author":"Kuster","year":"2020","journal-title":"Eur Heart J"},{"key":"R33-2-20240511","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.abb.2008.09.019","article-title":"Losartan, an antagonist of AT1 receptor for angiotensin II, attenuates lipopolysaccharide-induced acute lung injury in rat","volume":"481","author":"Liu","year":"2009","journal-title":"Arch Biochem Biophys"},{"key":"R34-2-20240511","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat Med"},{"key":"R35-2-20240511","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1161\/HYPERTENSIONAHA.114.03871","article-title":"Oral delivery of Angiotensin-converting enzyme 2 and Angiotensin-(1-7) bioencapsulated in plant cells attenuates pulmonary hypertension","volume":"64","author":"Shenoy","year":"2014","journal-title":"Hypertension"},{"key":"R36-2-20240511","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA - J Am Med Assoc"},{"key":"R37-2-20240511","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jacc.2020.06.007","article-title":"Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection","volume":"76","author":"Lala","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R39-2-20240511","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","volume":"5","author":"Guo","year":"2020","journal-title":"JAMA Cardiol"},{"key":"R40-2-20240511","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa1702090","article-title":"Acute myocardial infarction after laboratory-confirmed influenza infection","volume":"378","author":"Kwong","year":"2018","journal-title":"N Engl J Med"},{"key":"R41-2-20240511","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","volume":"5","author":"Shi","year":"2020","journal-title":"JAMA Cardiol"},{"key":"R42-2-20240511","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1056\/NEJMc2009020","article-title":"ST-segment elevation in patients with Covid-19 - A case series","volume":"382","author":"Bangalore","year":"2020","journal-title":"N Engl J Med"},{"key":"R43-2-20240511","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00134-020-05993-9","article-title":"How to balance acute myocardial infarction and COVID-19: The protocols from Sichuan Provincial People's Hospital","volume":"46","author":"Zeng","year":"2020","journal-title":"Intensive Care Med"},{"key":"R44-2-20240511","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1093\/eurheartj\/ehaa381","article-title":"EAPCI position statement on invasive management of acute coronary syndromes during the COVID-19 pandemic","volume":"41","author":"Chieffo","year":"2020","journal-title":"Eur Heart J"},{"key":"R45-2-20240511","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/S0140-6736(20)30912-0","article-title":"Myocarditis in a patient with COVID-19: A cause of raised troponin and ECG changes","volume":"395","author":"Doyen","year":"2020","journal-title":"Lancet"},{"key":"R46-2-20240511","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/jamacardio.2020.1096","article-title":"Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19)","volume":"5","author":"Inciardi","year":"2020","journal-title":"JAMA Cardiol"},{"key":"R47-2-20240511","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1093\/eurheartj\/ehaa286","article-title":"Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection","volume":"41","author":"Sala","year":"2020","journal-title":"Eur Heart J"},{"key":"R49-2-20240511","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1093\/eurheartj\/ehaa396","article-title":"Acute myocardial injury, MINOCA, or myocarditis? Improving characterization of coronavirus-associated myocardial involvement","volume":"41","author":"Peretto","year":"2020","journal-title":"Eur Heart J"},{"key":"R50-2-20240511","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s00059-020-04909-z","article-title":"SARS-CoV-2: Apotential novel etiology of fulminant myocarditis","volume":"45","author":"Chen","year":"2020","journal-title":"Herz"},{"key":"R53-2-20240511","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1161\/CIRCULATIONAHA.120.047971","article-title":"Spectrum of cardiac manifestations in COVID-19: A systematic echocardiographic study","volume":"142","author":"Szekely","year":"2020","journal-title":"Circulation"},{"key":"R54-2-20240511","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"R55-2-20240511","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1161\/CIRCRESAHA.120.317070","article-title":"SARS-CoV-2-induced immune dysregulation and myocardial injury risk in China: Insights from the ERS-COVID-19 study","volume":"127","author":"Li","year":"2020","journal-title":"Circ Res"},{"key":"R56-2-20240511","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s11899-020-00567-4","article-title":"The cardiovascular complications of chimeric antigen receptor T cell therapy","volume":"15","author":"Jamal","year":"2020","journal-title":"Curr Hematol Malig Rep"},{"key":"R57-2-20240511","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/jce.14479","article-title":"Cardiac and arrhythmic complications in patients with COVID-19","volume":"31","author":"Kochi","year":"2020","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R58-2-20240511","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/CM9.0000000000000744","article-title":"Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province","volume":"133","author":"Liu","year":"2020","journal-title":"Chin Med J (Engl"},{"key":"R59-2-20240511","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb Res"},{"key":"R60-2-20240511","doi-asserted-by":"crossref","first-page":"2001365","DOI":"10.1183\/13993003.01365-2020","article-title":"Pulmonary embolism in patients with COVID-19 pneumonia","volume":"56","author":"Bompard","year":"2020","journal-title":"Eur Respir J"},{"key":"R61-2-20240511","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/eurheartj\/ehaa254","article-title":"Acute pulmonary embolism and COVID-19 pneumonia: A random association?","volume":"41","author":"Danzi","year":"2020","journal-title":"Eur Heart J"},{"key":"R62-2-20240511","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.jaccas.2020.04.008","article-title":"COVID-19 complicated by acute pulmonary embolism and right-sided heart failure","volume":"2","author":"Ullah","year":"2020","journal-title":"JACC Case Rep"},{"key":"R63-2-20240511","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R64-2-20240511","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/jth.14817","article-title":"Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy","volume":"18","author":"Tang","year":"2020","journal-title":"J Thromb Haemost"},{"key":"R66-2-20240511","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/cvr\/cvaa106","article-title":"COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options","volume":"116","author":"Guzik","year":"2020","journal-title":"Cardiovasc Res"},{"key":"R67-2-20240511","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.hrthm.2020.05.014","article-title":"QT interval prolongation and torsade de pointes in patients with COVID-19 treated with hydroxychloroquine\/azithromycin","volume":"17","author":"Chorin","year":"2020","journal-title":"Heart Rhythm"},{"key":"R68-2-20240511","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N Engl J Med"},{"key":"R69-2-20240511","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1016\/j.jacc.2020.03.031","article-title":"Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic","volume":"75","author":"Driggin","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"R72-2-20240511","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/jama.2020.10044","article-title":"Effect of convalescent plasma therapy on time to clinical improvement in patients with severe and Life-threatening COVID-19: A randomized clinical trial","volume":"324","author":"Li","year":"2020","journal-title":"JAMA"},{"key":"R76-2-20240511","first-page":"1","article-title":"Dexamethasone in the management of covid -19","volume":"370","author":"Johnson","year":"2020","journal-title":"BMJ"},{"key":"R77-2-20240511","doi-asserted-by":"crossref","first-page":"9110","DOI":"10.1038\/s41598-017-09536-z","article-title":"Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after Infection","volume":"7","author":"Wu","year":"2017","journal-title":"Sci Rep"}],"container-title":["Heart and Mind"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/hm.hm_28_20","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T19:04:21Z","timestamp":1715454261000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.4103\/hm.hm_28_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.4103\/hm.hm_28_20","relation":{},"ISSN":["2468-6476"],"issn-type":[{"value":"2468-6476","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]}}}